Taiho Ventures LLC 3
3 · Werewolf Therapeutics, Inc. · Filed Apr 29, 2021
Insider Transaction Report
Form 3
Taiho Ventures LLC
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (1,318,311 underlying)Series B Preferred Stock
→ Common Stock (438,098 underlying)
Footnotes (2)
- [F1]The Series A Preferred Stock is convertible into common stock on a 8.6691-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
- [F2]The Series B Preferred Stock is convertible into common stock on a 8.6691-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.